메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국생약학회 생약학회지(Korean Journal of Pharmacognosy) 생약학회지 제45권 제1호
발행연도
2014.3
수록면
1 - 10 (10page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
Ginsenoside Rg3 (G-Rg3) is one of protopanaxadiol ginsenosides characteristic of red ginseng, steamed and driedginseng (Panax ginseng), which has recently attracted much attention for its antitumor properties in vitro and in vivo animalmodels. Experimental studies have demonstrated that it could promote cancer cell apoptosis, inhibit cancer cell growth, the apoptosisof cancer cells, adhesion, invasion and metastasis, and also prevent an angiogenetic formation in prostate, breast, ovarian,colorectal, gastric, liver and lung cancer etc. It has shown the antitumor activities by modulation of diverse signaling pathways,including regulation of cell proliferation mediators (CDKs and cyclins), growth factors (vascular endothelial growth factor),tumor suppressors (p53 and p21), cell death mediators (caspases, Bcl-2, Bax), inflammatory response molecules (NF-κB andCOX-2), protein kinases (JNK, Akt, and AMP-activated protein kinase) and Wnt/β-catenin signaling. In addition, the combinationof Rg3 and chemotherapeutic agents have synergistically enhanced therapeutic efficacy and reduced antagonisticallyside effects. Furthermore, it can reverse the multidrug resistance of cancer cells, prolong the survival duration and improve lifequality of cancer patients. Taken together, accumulating evidences could provide the potential of G-Rg3 in the treatment of cancers and the feasibility of further randomized placebo controlled clinical trials.

목차

등록된 정보가 없습니다.

참고문헌 (90)

참고문헌 신청

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2023-518-000068236